
    
      This is a prospective, multi-center, multi-phase, evaluator-blinded study of subjects
      undergoing a procedure to improve the appearance of lax tissue in the neck and submental
      region. All study subjects will be treated with the Renuvion APR Device.

      Phase I (n=17) of this study will be conducted primarily to provide safety data, however,
      effectiveness data will also be collected at the above stated timepoints through 6 months
      post-procedure.

      Phase II (n=65) of this study is the expansion of the study to a pivotal study.
    
  